Safety of pediatric HIV elimination: the growing population of HIV- and antiretroviral-exposed but uninfected infants.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 24781352.
- Also identified by DOI 10.1371/journal.pmed.1001636 and PMC identifier 4004531.
- Licence recorded as CC0.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Lynne Mofenson and Heather Watts discuss the context and implications of the study by J. Sibuide and colleagues, which provides a detailed analysis of birth defects in infants with in utero antiretroviral drug exposure in the French Perinatal Cohort. Please see later in the article for the Editors' Summary.
Medical subject headings
- Anti-HIV Agents
- Congenital Abnormalities
- HIV Infections
- Heart Defects, Congenital
- Prenatal Exposure Delayed Effects